iifl-logo-icon 1

Mankind Pharma Ltd Share Price

2,647
(-0.01%)
Oct 21, 2024|03:33:38 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,640.1
  • Day's High2,685.15
  • 52 Wk High2,835
  • Prev. Close2,647.2
  • Day's Low2,626
  • 52 Wk Low 1,683.05
  • Turnover (lac)3,598.7
  • P/E56.6
  • Face Value1
  • Book Value253.03
  • EPS46.79
  • Mkt. Cap (Cr.)1,06,050.5
  • Div. Yield0
View All Historical Data
No Records Found

Mankind Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

2,640.1

Prev. Close

2,647.2

Turnover(Lac.)

3,598.7

Day's High

2,685.15

Day's Low

2,626

52 Week's High

2,835

52 Week's Low

1,683.05

Book Value

253.03

Face Value

1

Mkt Cap (₹ Cr.)

1,06,050.5

P/E

56.6

EPS

46.79

Divi. Yield

0

Mankind Pharma Ltd Corporate Action

18 Jul 2024

12:00 AM

AGM

Announcement Date: 18 Jul, 2024

arrow

17 Sep 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Mankind Pharma Ltd NEWS AND UPDATE

CCI greenlights Mankind Pharma's Rs 13,630 crore takeover of Bharat Serums
3 Oct 2024|11:02 AM

Mankind announced in July that it would purchase the whole stake in Bharat Serums and Vaccines.

Read More
Top 10 stocks for today – 3rd October 2024
3 Oct 2024|09:07 AM

Here are some of the stocks that may see significant price movement today: Suzlon Energy, Aurobindo Pharma, Coal India, etc.

Read More
Top 10 stocks for today – 1st October 2024
1 Oct 2024|08:17 AM

Here are some of the stocks that may see significant price movement today: Tata Power, India Glycols, Jindal Stainless, etc.

Read More
Mankind Pharma board approves ₹10,000 Crore fund raise
30 Sep 2024|07:41 PM

The company will offer commercial papers on the BSE in numerous tranches ranging from three to twelve months

Read More
Mankind Pharma Announces NCD Fundraising Initiative
23 Sep 2024|01:56 PM

This strategic move is intended to streamline Mankind Pharma’s operations, enabling greater focus on its core pharmaceutical business.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd SHAREHOLDING SNAPSHOT

22 Oct, 2024|07:15 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 74.87%

Foreign: 0.00%

Indian: 74.87%

Non-Promoter- 21.52%

Institutions: 21.52%

Non-Institutions: 3.60%

Custodian: 0.00%

Share Price

Mankind Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

40.06

40.06

40.06

40.06

Preference Capital

0

0

0

0

Reserves

9,583.75

7,743.85

6,500.39

4,694.21

Net Worth

9,623.81

7,783.91

6,540.45

4,734.27

Minority Interest

View Balance Sheet

No Record Found

View Profit & Loss

No Record Found

View Cash Flow

No Record Found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

10,334.77

8,749.43

7,781.56

6,214.43

5,865.23

Excise Duty

0

0

0

0

0

Net Sales

10,334.77

8,749.43

7,781.56

6,214.43

5,865.23

Other Operating Income

0

0

0

0

0

Other Income

296.07

140.99

210.48

182.63

121.96

Mankind Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,897

163.494,55,021.88237.820.714,409.7498.75

Divis Laboratories Ltd

DIVISLAB

5,925

94.671,57,256.954300.512,063507.93

Cipla Ltd

CIPLA

1,523.75

30.971,22,988.411,055.940.853,752.25346.39

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,392.5

76.41,14,822.614690.832,394201.77

Dr Reddys Laboratories Ltd

DRREDDY

6,697.4

27.121,11,742.471,417.20.65,823.91,458.55

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Mankind Pharma Ltd

Management

Register Office

Registrar Office

Chairman & Wholetime Director

RAMESH CHAND JUNEJA

Vice Chairman & M.D.

RAJEEV JUNEJA

Whole Time Director & CEO

SHEETAL ARORA

Independent Director

TILOKCHAND PUNAMCHAND OSTWAL

Company Sec. & Compli. Officer

Pradeep Chugh

Independent Director

Bharat Anand

Whole-time Director

SATISH KUMAR SHARMA

Independent Director

Vivek Kalra

Independent Director

Vijaya Sampath

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Mankind Pharma Ltd. was incorporated on July 3, 1991, as a Private Limited Company with the name Mankind Pharma Private Limited, by the Registrar of Companies, Delhi and Haryana, at New Delhi. Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to Mankind Pharma Limited and the RoC issued a fresh Certificate of Incorporation on April 13, 2006.The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products. It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory. In 2004, the Company entered the chronic pharmaceutical segment with the launch of Amlokind tablets and Glimestar tablets amongst others. It set up their first manufacturing facility at Paonta Sahib, in Himachal Pradesh during year 2005. It entered the ophthalmic pharmaceutical segment with the launching of Lubistar Eye Drops and Tobastar Eye Drops. In 2007, the Company entered the consumer healthcare segment with the launch of Manforce brand and have since established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineralsupplements and anti-acne preparations categories. It entered into the business of animal heal
Read More

Company FAQs

What is the Mankind Pharma Ltd share price today?

The Mankind Pharma Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹2647 today.

What is the Market Cap of Mankind Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mankind Pharma Ltd is ₹106050.50 Cr. as of 21 Oct ‘24

What is the PE and PB ratio of Mankind Pharma Ltd?

The PE and PB ratios of Mankind Pharma Ltd is 56.6 and 11.03 as of 21 Oct ‘24

What is the 52 Week High and Low of Mankind Pharma Ltd?

The 52-week high/low is the highest and lowest price at which a Mankind Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Mankind Pharma Ltd is ₹1683.05 and ₹2835 as of 21 Oct ‘24

What is the CAGR of Mankind Pharma Ltd?

Mankind Pharma Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 51.31%, 6 Month at 13.10%, 3 Month at 25.55% and 1 Month at -0.12%.

What is the shareholding pattern of Mankind Pharma Ltd?

The shareholding pattern of Mankind Pharma Ltd is as follows:
Promoters - 74.87 %
Institutions - 21.52 %
Public - 3.61 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp